Interactive Session:
112. Challenging HIV Cases
Friday, October 6, 2017: 8:30 AM-10:00 AM
Room: 20ABCD

Learning Objectives:

At the conclusion of this session, participants will be able to:

  • identify complicating factors in HIV-infected patients
  • apply strategies to address treatment complications in HIV-infected patients
  • choose between different treatment strategies or managing HIV-infected patients

Target Audience: Clinicians, Fellows, HIV clinicians, HIV specialists, Infectious diseases pediatricians, Pharmacists, Public health practitioners

Tracks: HIV-STD-TB, Adult ID


Chair:  Jeanne Marrazzo, MD, MPH, FIDSA, FACP, University of Alabama at Birmingham School of Medicine

Interactive Moderators:  Paul Sax, MD, Brigham and Women's Hospital and Charlene Flash, MD, MPH, Baylor College of Medicine

Interactive Panelists:  Richard Hamill, MD, FIDSA, Baylor College of Medicine & Michael E. DeBakey VA Medical Center , Edgar Overton, MD, University of Alabama at Birmingham , Charles Hicks, MD, Duke University Medical Center and Shireesha Dhanireddy, MD, University of Washington

CME Credits: Maximum of 1.50 hours of AMA PRA Category 1 Credit™

ACPE Credits: ACPE 1.5 application-based contact hours of pharmacy CE

ACPE Number: 0221-9999-17-265-L02-P

Disclosures:

J. Marrazzo, None

P. Sax, Gilead: Consultant and Investigator , Consulting fee , Research grant and Research support
BMS: Consultant and Investigator , Consulting fee , Research grant and Research support
GlaxoSmithKline/ViiV: Consultant and Investigator , Consulting fee , Research grant and Research support
AbbVie: Consultant , Consulting fee
Janssen: Consultant , Consulting fee
Merck: Consultant , Consulting fee

C. Flash, Gilead Sciences: Scientific Advisor , Consulting fee

R. Hamill, None

C. Hicks, Merck: Consultant and Scientific Advisor , Consulting fee
Gilead Sciences, Inc.: Consultant and Scientific Advisor , Consulting fee
Janssen: Consultant and Scientific Advisor , Consulting fee
ViiV: Consultant and Scientific Advisor , Consulting fee

S. Dhanireddy, None

See more of: Interactive Session

Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 4th with the exception of research findings presented at the IDWeek press conferences.